Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.kamronlabs.com | |
Market Cap | 3.32 Cr. | |
Enterprise Value(EV) | 4.56 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -5.01 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.22 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | -2.65 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | -2.14 | Calculated using Price: 5.67 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.59 Cr. | 5,850,000 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is engaged primarily in business of manufacturing pharmaceutical products. The company has also stared trading in grey fabrics. |
1 Day |
|
|
1 Week |
|
+5.00% |
1 Month |
|
+6.98% |
3 Month |
|
-47.55% |
6 Month |
|
-35.20% |
1 Year |
|
-42.38% |
2 Year |
|
+8.00% |
5 Year |
|
-20.59% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 0.14 | 0.42 | 0.20 | 0.21 | 0.06 | 1.02 | -127.09 | -49.89 | 31.35 | |
Return on Capital Employed (%) | 4.75 | 3.83 | 3.16 | 2.46 | 2.55 | 0.93 | -49.36 | -23.82 | 16.18 | |
Return on Assets (%) | 0.05 | 0.13 | 0.06 | 0.04 | 0.01 | 0.12 | -25.58 | -19.42 | 13.66 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 7 | 7 | 7 | 7 | 7 | 7 | 3 | 2 | 3 | -2 | |
Non Curr. Liab. | 5 | 6 | 5 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 5 | 6 | 7 | 9 | 12 | 15 | 4 | 3 | 2 | 1 | |
Minority Int. | |||||||||||
Equity & Liab. | 17 | 19 | 18 | 21 | 23 | 22 | 8 | 6 | 5 | 0 | |
Non Curr. Assets | 10 | 12 | 12 | 13 | 13 | 12 | 5 | 4 | 4 | ||
Curr. Assets | 5 | 6 | 5 | 5 | 7 | 6 | 3 | 2 | 0 | 0 | |
Misc. Exp. not W/O | 2 | 1 | 2 | 3 | 4 | 4 | |||||
Total Assets | 17 | 19 | 18 | 21 | 23 | 22 | 8 | 6 | 5 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 13 | 15 | 17 | 17 | 8 | 6 | 7 | 6 | 1 | 0 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Total Income | 13 | 15 | 17 | 17 | 8 | 6 | 7 | 6 | 1 | 1 | |
Total Expenditure | -12 | -14 | -16 | -16 | -7 | -5 | -10 | -7 | -1 | -1 | |
PBIDT | 1 | 1 | 1 | 1 | 1 | 1 | -3 | 0 | 0 | 0 | |
Interest | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Depreciation | 0 | -1 | 0 | -1 | -1 | -1 | 0 | -1 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | ||||||
Exceptional Items | 0 | 1 | -3 | ||||||||
PAT | 0 | 0 | 0 | 0 | 0 | -4 | -1 | 1 | -3 | ||
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | -6 | -2 | 1 | -5 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 2 | 1 | 0 | 1 | 2 | 1 | -1 | -11 | 0 | 0 | |
Cash Fr. Inv. | -1 | -1 | -2 | 0 | -3 | -3 | 0 | 11 | 0 | ||
Cash Fr. Finan. | -1 | 0 | 2 | -1 | 1 | 4 | 0 | 0 | 0 | 0 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 2 | -2 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
Wed, 01 Feb 2023
Board Meeting Intimation for Taking On Record Unaudited Financial Results For The Quarter Ended On 31St December 2022 Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Unaudited Financial Results for the quarter ended on 31st December 2022 |
Thu, 05 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 We are hereby submitting the certificate issued by Link In time India Private Limited Registrar and Share Transfer Agent of the Company for the Quarter ended on 31st December 2022. |
Mon, 26 Dec 2022
Closure of Trading Window Pursuant to BSEs Circular No. LIST/COMP/01/2019-20 dated 2nd April 2019 and as per Clause 4 of the Schedule B and other applicable regulations of SEBI (Prohibition of Insider Trading) Regulations 2015 this is to inform you that in terms of Companys Code of Conduct for Prevention of Insider Trading the Trading Window of the Company will remain closed with effect from 1st January 2023 till 48 hours after the declaration of Unaudited Financial Results for the quarter ended on 31st December 2022. |
Thu, 02 Feb 2023 |
|
|
|
|
|